Xu et al. showed that IGF2BP2 was identified as a direct target of miR-141, and the miR-141/IGF2BP2 axis promoted pancreatic cancer cell proliferation by activating the PI3K/Akt pathway in vitro and in vivo90. Here, PIK3CB is linked to pancreatic neoplasm.